Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours
- 1 January 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (2), 230-239
- https://doi.org/10.1016/s0959-8049(02)00497-5
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effects of p21Waf1/Cip1/Sdi1on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseasesProceedings of the National Academy of Sciences, 2000
- Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors.Carcinogenesis: Integrative Cancer Research, 1999
- Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cellsNature, 1998
- Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibitionOncogene, 1997
- Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53Proceedings of the National Academy of Sciences, 1997
- The biology of replicative senescenceEuropean Journal Of Cancer, 1997
- Replicative Senescence: Implications for in Vivo Aging and Tumor SuppressionScience, 1996
- Refining the telomere-telomerase hypothesis of aging and cancerNature Biotechnology, 1996
- A biomarker that identifies senescent human cells in culture and in aging skin in vivo.Proceedings of the National Academy of Sciences, 1995
- Purification of human liver acid β-d-galactosidases using affinity chromatographyAnalytical Biochemistry, 1976